Skip to main content
. 2021 Oct 26;41(11):1195–1227. doi: 10.1002/cac2.12218

FIGURE 1.

FIGURE 1

Individualized follow‐up strategy for patients with nasopharyngeal carcinoma. For patients in subgroup 1, the risk‐based follow‐up arrangement is a total of 10 follow‐up visits within 5 years (No. of follow‐up for the first 1 to 5 years, sequentially: 2, 3, 2, 2, and 1 per year, respectively); patients in subgroup 2 require a total of 11 follow‐up visits (No. of follow‐up for the first 1 to 5 years, sequentially: 2, 4, 2, 2, and 1 per year, respectively); subgroup 3 patients need a total of 13 follow‐up visits (No. of follow‐up for the first 1 to 5 years, sequentially: 4, 4, 3, 1, and 1 per year, respectively); subgroup 4 patients require a total of 14 follow‐up visits (No. of follow‐up for the first 1 to 5 years, sequentially: 4, 5, 3, 1, and 1 per year, respectively)